Cargando…

The Expression of Circulating miR-497 and Metadherin in Hepatocellular Carcinoma: Relation to the Tumor Characteristics and Patients’ Survival

Objectives: This study aimed to evaluate the prognostic significance and relationship of miR-497 and metadherin to hepatocellular carcinoma (HCC) tumor characteristics and patients’ survival. Methods: This study enrolled 120 (60 HCC patients and 60 healthy) subjects. Serum miR-497 and metadherin mRN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ali, Dina A., Sabry, Nesreen M., Kabel, Ahmed M., Gaber, Rasha A., Mokhtar, Hwaida M., Samy, Sara M., Elrashidy, Mohamed A., Salama, Samir A., Abdelhai, Dina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468780/ https://www.ncbi.nlm.nih.gov/pubmed/34577789 http://dx.doi.org/10.3390/medicina57090866

Ejemplares similares

The Prognostic Significance of MACC1 Expression in Breast Cancer and Its Relationship to Immune Cells in the Tumor Microenvironment and Patient Survival
por: Ali, Dina A., et al.
Publicado: (2021)

The Significance of FDG PET/CT–Derived Parameters in Determining Prognosis of Cases with Pancreatic Adenocarcinoma: A Prospective Study
por: Mokhtar, Hwaida M., et al.
Publicado: (2022)

MicroRNA-497-5p Functions as a Modulator of Apoptosis by Regulating Metadherin in Ovarian Cancer
por: Liu, Chunyan, et al.
Publicado: (2020)

Expression and Diagnostic Value of miR-497 and miR-1246 in Hepatocellular Carcinoma
por: Chen, Shuying, et al.
Publicado: (2021)

Metadherin Is a Prognostic Predictor of Hepatocellular Carcinoma after Curative Hepatectomy
por: Ahn, Soomin, et al.
Publicado: (2013)

MiR-630 suppresses breast cancer progression by targeting metadherin
por: Zhou, Ci-Xiang, et al.
Publicado: (2015)

Target gene regulatory network of miR-497 in angiosarcoma
por: Benton, Annaleigh, et al.
Publicado: (2023)

SSRP1 Contributes to the Malignancy of Hepatocellular Carcinoma and Is Negatively Regulated by miR-497
por: Ding, Qianshan, et al.
Publicado: (2016)

Hypoxia-induced autophagy in triple negative breast cancer: association with prognostic variables, patients’ survival and response to neoadjuvant chemotherapy
por: El-Guindy, Dina M., et al.
Publicado: (2023)

Metadherin: A Therapeutic Target in Multiple Cancers
por: Dhiman, Gourav, et al.
Publicado: (2019)

Metadherin enhances vulnerability of cancer cells to ferroptosis
por: Bi, Jianling, et al.
Publicado: (2019)

Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer
por: Du, Mulong, et al.
Publicado: (2015)

MicroRNA-466 inhibits the aggressive behaviors of hepatocellular carcinoma by directly targeting metadherin
por: Jia, Chen, et al.
Publicado: (2022)

Metadherin Regulates Inflammatory Breast Cancer Invasion and Metastasis
por: Ortiz-Soto, Gabriela, et al.
Publicado: (2023)

MiR-128 suppresses metastatic capacity by targeting metadherin in breast cancer cells
por: Cao, Danxia, et al.
Publicado: (2020)

MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1
por: Yan, Jing-Jun, et al.
Publicado: (2015)

miR-497/MIR497HG inhibits glioma cell proliferation by targeting CCNE1 and the miR-588/TUSC1 axis
por: Ji, Li-Ya, et al.
Publicado: (2021)

Identification of Novel Variants of Metadherin in Breast Cancer
por: Liu, Xianqiang, et al.
Publicado: (2011)

Metadherin regulates epithelial–mesenchymal transition in carcinoma
por: Wang, Zhao, et al.
Publicado: (2016)

Metadherin facilitates podocyte apoptosis in diabetic nephropathy
por: Liu, Wen-Ting, et al.
Publicado: (2016)

Role of metadherin in estrogen-regulated gene expression
por: Li, Yujun, et al.
Publicado: (2017)

Metadherin is an apoptotic modulator in prostate cancer through miR-342-3p regulation
por: Hu, Kebang, et al.
Publicado: (2018)

MIR497HG‐Derived miR‐195 and miR‐497 Mediate Tamoxifen Resistance via PI3K/AKT Signaling in Breast Cancer
por: Tian, Yao, et al.
Publicado: (2023)

Immunohistochemical analysis of Metadherin in proliferative and cancerous breast tissue
por: Su, Peng, et al.
Publicado: (2010)

Ameliorative Potential of L-Alanyl L-Glutamine Dipeptide in Colon Cancer Patients Receiving Modified FOLFOX-6 Regarding the Incidence of Diarrhea, the Treatment Response, and Patients’ Survival: A Randomized Controlled Trial
por: Sabry, Nesreen M., et al.
Publicado: (2022)

The Tumor-Suppressive miR-497-195 Cluster Targets Multiple Cell-Cycle Regulators in Hepatocellular Carcinoma
por: Furuta, Mayuko, et al.
Publicado: (2013)

The Maturation of Tumor Suppressor miR-497 in Hepatocellular Carcinoma is Inhibited by Oncogenic circRNA SCARB1
por: Zhu, Shuo, et al.
Publicado: (2021)

miR-497 expression, function and clinical application in cancer
por: Yang, Gang, et al.
Publicado: (2016)

miR-384 targets metadherin gene to suppress growth, migration, and invasion of gastric cancer cells
por: Wang, Fang
Publicado: (2019)

Dyslipidemia initiates keratinocytes proliferation through upregulation of lncRNA NEAT in psoriasis patients
por: Mostafa, Abeer, et al.
Publicado: (2023)

Bone Marrow-Derived Mesenchymal Stem Cells and γ-Secretase Inhibitor Treatments Suppress Amyloid-β25–35-Induced Cognitive Impairment in Rat Dams and Cortical Degeneration in Offspring
por: Gaber, Asmaa, et al.
Publicado: (2023)

Metadherin–PRMT5 complex enhances the metastasis of hepatocellular carcinoma through the WNT–β-catenin signaling pathway
por: Zhu, Kai, et al.
Publicado: (2020)

LINC02476 Promotes the Malignant Phenotype of Hepatocellular Carcinoma by Sponging miR-497 and Increasing HMGA2 Expression
por: Duan, Yuxia, et al.
Publicado: (2020)

miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma
por: Dong, Ruifen, et al.
Publicado: (2014)

Metadherin Contributes to the Pathogenesis of Diffuse Large B-cell Lymphoma
por: Ge, Xueling, et al.
Publicado: (2012)

Targeting Oxidative Stress, NLRP3 Inflammasome, and Autophagy by Fraxetin to Combat Doxorubicin-Induced Cardiotoxicity
por: Kabel, Ahmed M., et al.
Publicado: (2021)

LINC02476 Promotes the Malignant Phenotype of Hepatocellular Carcinoma by Sponging miR-497 and Increasing HMGA2 Expression [Retraction]
Publicado: (2022)

Co-targeting of IGF1R/mTOR pathway by miR-497 and miR-99a impairs hepatocellular carcinoma development
por: Cheng, Henghui, et al.
Publicado: (2017)

GATA-4, a potential novel therapeutic target for high-grade meningioma, regulates miR-497, a potential novel circulating biomarker for high-grade meningioma
por: Negroni, Caterina, et al.
Publicado: (2020)

Circular RNA Circ-03955 Promotes Epithelial-Mesenchymal Transition in Osteosarcoma by Regulating miR-3662/Metadherin Pathway
por: Wang, Zhengguang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_49bqnjksh1053j7lm81jct6vms